Author:
Santis Maria De,Steininger Tanja
Publisher
Springer Berlin Heidelberg
Reference6 articles.
1. Berelowitz KS, Wolf C, Täubel J (2011) Benefits of a single versus multicenter approach in early-phase patient studies. A case study of multiple sclerosis patients. Monitor (Assoc Clin Pharmacol) 25(10):21–5
2. Bezwoda W (1999) Randomised, controlled trial of high dose chemotherapy (HD-CNVp) versus standard dose (CAF) chemotherapy for high risk, surgically treated, primary breast cancer (Meeting abstract). ASCO annual meeting. (Retrieved Dezember 2012)
3. Cleaton-Jones P (2000) Scientific misconduct in a breast-cancer chemotherapy trial: response of University of the Witwatersrand. The Lancet 355(9208):1011–1012
4. Dechartres A, Boutron I, Trinquart L, Charles P, Ravaud P (2011) Single-center trials show larger treatment effects than multicenter trials: evidence from a meta-epidemiologic study. Ann Intern Med 155(1):39–51
5. Localio AR, Berlin JA, Ten Have TR, Kimmel SE (2001) Adjustments for center in multicenter studies: an overview. Ann Intern Med. 135(2):112–123